文献速递帕金森病与运动障碍

帕金森病结构变异的全基因组分析

Genome-Wide Analysis of Structural Variants in Parkinson Disease.
PubMed 文献 · Ann Neurol · 2023-02-03

本研究利用计算流程从7772例Illumina短读长全基因组测序样本中检测并基因分型结构变异(SV),在2585例病例和2779例对照中进行全基因组关联分析,鉴定与帕金森病(PD)风险相关的SV,并用长读长测序验证了三个新型缺失SV与PD风险相关,包括LRRN4基因内一个2 kb内含子缺失。

要点

  • 长读长测序数据验证了三个与PD风险相关的新型缺失SV,包括LRRN4基因内一个2 kb内含子缺失。
  • 本研究是迄今对SV在PD遗传风险中贡献的最全面评估。

核心结论

  • 鉴定出三个与帕金森病遗传风险相关的结构变异。

研究设计与样本

  • 利用计算流程从7772例Illumina短读长全基因组测序样本中检测并基因分型结构变异(SV)。
  • 使用2585例病例和2779例对照进行全基因组关联分析。
  • 生成匹配的全基因组长读长测序数据子集以验证变异存在。

主要发现

  • 长读长测序数据验证了三个与PD风险相关的新型缺失SV,包括LRRN4基因内一个2 kb内含子缺失。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Identification of genetic risk factors for Parkinson disease (PD) has to date been primarily limited to the study of single nucleotide variants, which only represent a small fraction of the genetic variation in the human genome. Consequently, causal variants for most PD risk are not known. Here we focused on structural variants (SVs), which represent a major source of genetic variation in the human genome. We aimed to discover SVs associated with PD risk by performing the first large-scale characterization of SVs in PD. METHODS: We leveraged a recently developed computational pipeline to detect and genotype SVs from 7,772 Illumina short-read whole genome sequencing samples. Using this set of SV variants, we performed a genome-wide association study using 2,585 cases and 2,779 controls and identified SVs associated with PD risk. Furthermore, to validate the presence of these variants, we generated a subset of matched whole-genome long-read sequencing data. RESULTS: We genotyped and tested 3,154 common SVs, representing over 412 million nucleotides of previously uncatalogued genetic variation. Using long-read sequencing data, we validated the presence of three novel deletion SVs that are associated with risk of PD from our initial association analysis, including a 2 kb intronic deletion within the gene LRRN4. INTERPRETATION: We identified three SVs associated with genetic risk of PD. This study represents the most comprehensive assessment of the contribution of SVs to the genetic risk of PD to date. ANN NEUROL 2023;93:1012-1022.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Billingsley KJ, Ding J, Jerez PA, et al. Genome-Wide Analysis of Structural Variants in Parkinson Disease. Ann Neurol. 2023. PMID: 36695634. doi:10.1002/ana.26608

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。